Crosslinked Micelle Core Stabilization via Metal Ion Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug delivery systems, particularly polymer micelles, face challenges with premature dissociation due to dilution and biological barriers, leading to reduced efficacy and increased toxicity, as they lack stability and specificity in targeting diseased cells.
Innovation Solution
Development of multiblock copolymers with a hydrophilic shell and a crosslinkable or crosslinked hydrophobic core, utilizing hydroxamic acid or catechol moieties for metal ion binding, which stabilizes the micelles and enhances their circulation time and targeting capabilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If polymer micelles are used for drug delivery, then drug loading capacity is improved, but in vivo stability deteriorates due to premature dissociation
Solution Approach 1:
The patent applies preliminary action by incorporating crosslinkable functional groups (hydroxamic acid or catechol moieties) into the copolymer structure before micelle formation. These groups are pre-positioned to enable subsequent crosslinking with metal ions (Fe3+, Cu2+, Zn2+) that will stabilize the micelle core, preventing premature dissociation while maintaining high drug loading capacity
Solution Approach 2:
The patent employs composite materials by combining organic copolymers with inorganic metal ions to create a hybrid crosslinked core. The metal ions form coordination bonds with the functional groups in the hydrophobic core, creating a composite structure that enhances micelle stability without compromising drug loading capacity
2Duration of action of moving object
If polymer micelles are used for drug delivery, then circulation time is extended, but specificity to diseased cells deteriorates
Solution Approach 1:
The patent applies local quality by differentiating the properties of different micelle regions: the core provides stability and circulation time, while the shell provides targeting specificity. The shell is functionalized with PEG for steric stabilization and long circulation, plus targeting ligands (folate, RGD peptide, or antibody) that provide disease-specific targeting, thus resolving the contradiction between circulation time and specificity
3Reliability
If crosslinking is introduced to stabilize micelles, then in vivo stability is improved, but micelle formation complexity increases
Solution Approach 1:
The patent applies self-service by designing copolymers with built-in crosslinkable functional groups (hydroxamic acid or catechol) that automatically react with metal ions to form crosslinked networks. This self-crosslinking mechanism occurs spontaneously upon contact with endogenous metal ions in the body, eliminating the need for external crosslinking agents or complex formation procedures while achieving enhanced in vivo stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The stabilized micelles exhibit improved in vivo stability, prolonged circulation, and enhanced specificity to diseased tissues, leading to increased drug delivery efficiency and reduced toxicity.
Implementation Method 1
utilizing hydroxamic acid or catechol moieties for metal ion binding
Data Source
AI summary
The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same. Compositions herein are useful for drug-delivery applications.